{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:49:07Z","timestamp":1790264947917,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1053\/j.ajkd.2013.05.009","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:02:22Z","timestamp":1372377742000},"page":"1176-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Pathogenesis of ANCA-Associated Vasculitis: New Possibilities for Intervention"],"prefix":"10.1053","volume":"62","clinical-trial-number":[{"clinical-trial-number":"nct01363388","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Cees G.M.","family":"Kallenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen A.","family":"Stegeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayel H.","family":"Abdulahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2013.05.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2013.05.009_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.2011.04358.x","article-title":"Nomenclature and classification of vasculitis\u2014update on the ACR\/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS)","volume":"164","author":"Luqmani","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrrheum.2010.158","article-title":"ANCA-associated vasculitides\u2014advances in pathogenesis and treatment","volume":"6","author":"Chen","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib5","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/art.21253","article-title":"Churg-Strauss syndrome: just one disease entity?","volume":"52","author":"Kallenberg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib6","doi-asserted-by":"crossref","first-page":"643.e9","DOI":"10.1016\/j.amjmed.2006.08.016","article-title":"ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis","volume":"120","author":"Finkielman","year":"2007","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrneph.2009.67","article-title":"ANCA-negative pauci-immune crescentic glomerulonephritis","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib8","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasma antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2014a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ajkd.2013.05.009_bib10","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","article-title":"Antiproteinase 3- and antimyeloperoxidase-associated vasculitis","volume":"57","author":"Franssen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","article-title":"Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement","volume":"93","author":"Bansal","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1053\/j.ajkd.2009.02.016","article-title":"Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis","volume":"54","author":"Silva","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2013.05.009_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2249.2011.04372.x","article-title":"Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes","volume":"164","author":"Bruner","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2249.2010.04251.x","article-title":"Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener's granulomatosis","volume":"162","author":"Bruner","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2013.05.009_bib19","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.30362","article-title":"Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)","volume":"63","author":"Espy","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.177.4.905","article-title":"Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model","volume":"177","author":"Brouwer","year":"1993","journal-title":"J Exp Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib21","first-page":"1695","article-title":"Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat","volume":"149","author":"Heeringa","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic antibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2013.05.009_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","article-title":"Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha","volume":"167","author":"Huugen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","article-title":"Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis","volume":"29","author":"Xing","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib28","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2013.05.009_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1681\/ASN.2007111166","article-title":"Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo","volume":"19","author":"Nolan","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib30","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1681\/ASN.2006020108","article-title":"Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis","volume":"17","author":"Ruth","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1681\/ASN.2009070763","article-title":"Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis","volume":"21","author":"Gan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib32","doi-asserted-by":"crossref","first-page":"E2615","DOI":"10.1073\/pnas.1210147109","article-title":"The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis","volume":"109","author":"Ooi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2013.05.009_bib33","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2013.05.009_bib34","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/ard.2006.064626","article-title":"Rats and mice immunized with chimeric human\/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes","volume":"66","author":"Van der Geld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2013.05.009_bib35","doi-asserted-by":"crossref","first-page":"e28626","DOI":"10.1371\/journal.pone.0028626","article-title":"Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system","volume":"7","author":"Little","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2013.05.009_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2249.2009.04072.x","article-title":"Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis","volume":"159","author":"Primo","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib37","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2013.05.009_bib38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.ki.5000167","article-title":"IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis","volume":"69","author":"Hewins","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib40","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar3873","article-title":"C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"14","author":"Yuan","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1053\/j.ajkd.2013.05.009_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jlb.50.6.539","article-title":"Antibodies against granule proteins activate neutrophils in vitro","volume":"50","author":"Charles","year":"1991","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1523-1755.2005.00431.x","article-title":"Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils","volume":"68","author":"Van Rossum","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-5793(95)01073-N","article-title":"Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool","volume":"374","author":"Halbwachs-Mecarelli","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1053\/j.ajkd.2013.05.009_bib44","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib45","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib46","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1189\/jlb.0604319","article-title":"Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies","volume":"76","author":"Van Rossum","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib47","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/art.24442","article-title":"Coexpression of CD 177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils","volume":"60","author":"Hu","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib48","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1074\/jbc.M110.171256","article-title":"Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation","volume":"286","author":"Jenke","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2013.05.009_bib49","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1681\/ASN.V1071506","article-title":"In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis","volume":"10","author":"Franssen","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib50","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","article-title":"Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamme RIIa","volume":"153","author":"Porges","year":"1994","journal-title":"J Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.1994.tb06137.x","article-title":"Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process","volume":"98","author":"Mulder","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.1995.tb08343.x","article-title":"Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA","volume":"101","author":"Mulder","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/1529-0131(199909)42:9<1823::AID-ANR5>3.0.CO;2-X","article-title":"Fc-gamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse","volume":"42","author":"Dijstelbloem","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib54","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.4049\/jimmunol.161.12.6909","article-title":"Antineutrophil cytoplasmic antibodies preferentially engage Fc gamma RIIIb on human neutrophils","volume":"161","author":"Kocher","year":"1998","journal-title":"J Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib55","doi-asserted-by":"crossref","first-page":"20736","DOI":"10.1073\/pnas.1109227109","article-title":"IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis","volume":"108","author":"Kelley","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2013.05.009_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.1202611","article-title":"Neutrophil activating potential of antineutrophil cytoplasm autoantibodies","volume":"74","author":"Rarok","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2249.2012.04615.x","article-title":"How anti-neutrophil cytoplasmic autoantibodies activate neutrophils","volume":"169","author":"Kettritz","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib58","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1681\/ASN.2006090973","article-title":"Antineutrophil cytoplasm antibody-stimulated neutrophil adhesion depends on diacylglycerol kinase-catalyzed phosphatidic acid formation","volume":"18","author":"Williams","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib59","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/01.ASN.0000019411.36000.06","article-title":"Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils","volume":"13","author":"Kettritz","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ki.2009.420","article-title":"Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis","volume":"77","author":"Schreiber","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib61","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/ard.2010.129106","article-title":"Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo","volume":"70","author":"Van der Veen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2013.05.009_bib62","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood.V86.8.3189.3189","article-title":"Effect of tumor necrosis factor-induced integrin activation of Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies","volume":"86","author":"Reumaux","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2013.05.009_bib63","first-page":"335","article-title":"Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells","volume":"141","author":"Savage","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib64","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2","article-title":"Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells","volume":"44","author":"Radford","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.2011030298","article-title":"Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles","volume":"23","author":"Hong","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib66","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1136\/ard.2011.153890","article-title":"ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant process","volume":"70","author":"Holden","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2013.05.009_bib67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib68","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2012-03-416156","article-title":"Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity","volume":"120","author":"Sangaletti","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2013.05.009_bib69","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis","volume":"35","author":"Schmitt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.1993.tb05918.x","article-title":"Serum markers of T cell activation in relapses of Wegener's granulomatosis","volume":"91","author":"Stegeman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib71","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0091-6749(99)70434-3","article-title":"Differential B- and T-cell activation in Wegener's granulomatosis","volume":"103","author":"Popa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib72","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/art.30366","article-title":"CD4+CD28- T-cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality","volume":"63","author":"Morgan","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib73","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1994.tb05511.x","article-title":"T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis","volume":"98","author":"Brouwer","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib74","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.ki.5001670","article-title":"Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis","volume":"70","author":"Abdulahad","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.05.009_bib75","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/art.24747","article-title":"Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Abdulahad","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2013.05.009_bib76","first-page":"149","article-title":"Increased frequency of circulating follicular helper T-cells in patients with granulomatosis with polyangiitis","volume":"164","author":"Abdulahad","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib77","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.23557","article-title":"Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission","volume":"58","author":"Abdulahad","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib78","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/ndt\/gfp783","article-title":"Serum IL-17 and IL-23 levels and autoantigenic-specific Th17 cells are elevated in patients with ANCA-associated vasculitis","volume":"25","author":"Nogueira","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2013.05.009_bib79","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.22692","article-title":"Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission","volume":"56","author":"Abdulahad","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib80","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"key":"10.1053\/j.ajkd.2013.05.009_bib81","doi-asserted-by":"crossref","first-page":"e18734","DOI":"10.1371\/journal.pone.0018734","article-title":"Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Rimbert","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2013.05.009_bib82","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.27403","article-title":"Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody associated vasculitis: the role of Treg cells and tryptophan degradation","volume":"62","author":"Chavele","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2013.05.009_bib83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib84","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V121134","article-title":"Silical exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis","volume":"12","author":"Hogan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib85","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.03501006","article-title":"Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study","volume":"2","author":"Hogan","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/ar392","article-title":"Staphylococcus aureus and Wegener's granulomatosis","volume":"4","author":"Popa","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1053\/j.ajkd.2013.05.009_bib88","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kem022","article-title":"Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ajkd.2013.05.009_bib89","doi-asserted-by":"crossref","first-page":"e24315","DOI":"10.1371\/journal.pone.0024315","article-title":"Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis","volume":"6","author":"Tadema","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2013.05.009_bib90","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/keq375","article-title":"Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission","volume":"50","author":"Tadema","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ajkd.2013.05.009_bib91","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2172-9-34","article-title":"CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis","volume":"9","author":"Hurtado","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib93","doi-asserted-by":"crossref","first-page":"e17972","DOI":"10.1371\/journal.pone.0017972","article-title":"Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA associated vasculitis","volume":"6","author":"Tadema","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2013.05.009_bib94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.181.2.585","article-title":"A novel class of autoantigens in anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells","volume":"181","author":"Kain","year":"1995","journal-title":"J Exp Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib95","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib96","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2011090920","article-title":"High prevalence of autoantibodies to hLamp-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"23","author":"Kain","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib97","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2011030273","article-title":"Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis","volume":"23","author":"Roth","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib98","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar3797","article-title":"Progress in treatment of ANCA-associated vasculitis","volume":"14","author":"Smith","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 2","key":"10.1053\/j.ajkd.2013.05.009_bib99","doi-asserted-by":"crossref","first-page":"ii62","DOI":"10.1136\/annrheumdis-2012-202195","article-title":"Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?","volume":"72","author":"Kallenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2013.05.009_bib100","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.05.009_bib101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2013.05.009_bib103","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613008871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613008871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:10:51Z","timestamp":1759457451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638613008871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0272638613008871"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.05.009","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of ANCA-Associated Vasculitis: New Possibilities for Intervention","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}